VICTORIA, British Columbia, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, today announced its financial results for the second quarter of 2025 and provided a business update. All dollar values are in U.S. dollars unless stated otherwise.
60 finalists for SG60 milestone edition selected by an international panel of judges and visionary partnersFocus on empowering Urban Solutions and Sustainability to solve...
TAIPEI, Aug. 8, 2025 /PRNewswire/ -- WCC Biomedical, a leader in novel drug delivery systems, will attend the upcoming NACDS Total Store Expo (TSE), where...
BANGALORE, India, Aug. 7, 2025 /PRNewswire/ --
What is the Market Size of Chain Transfer Agents Market?
The global market for Chain Transfer Agents was valued...
DELRAY BEACH, Fla., Aug. 6, 2025 /PRNewswire/ -- The report "Asphalt Additive Market by Type (Polymeric Modifiers, Anti-Strip & Adhesion Promoters, Emulsifiers, Chemical Modifiers, Rejuvenators, Fibers,...
DELRAY BEACH, Fla., Aug. 6, 2025 /PRNewswire/ -- The report "Asphalt Additive Market by Type (Polymeric Modifiers, Anti-Strip & Adhesion Promoters, Emulsifiers, Chemical Modifiers, Rejuvenators, Fibers,...
BANGKOK, Aug. 5, 2025 /PRNewswire/ -- Chulalongkorn University's "High-Protein Jelly Pudding with Modified Texture for the Elderly with Swallowing Difficulties," developed by Asst. Prof....
The growth of the Vinyl Ester Resin Market is primarily driven by increasing demand for corrosion-resistant materials across industries such as marine, chemical processing,...
The growth of the Vinyl Ester Resin Market is primarily driven by increasing demand for corrosion-resistant materials across industries such as marine, chemical processing,...
BEIJING, Aug. 3, 2025 /PRNewswire/ -- Raytone Biotech, a clinical-stage biotechnology company dedicated to innovative ophthalmic therapies, announced that it successfully completed the first patient...